Organization of Cell Sheet Tissue Engineering Regenerative
Medicine initiative (CSTERM)
CSTERM was established in March 2017 as a non-profit supporting organization
for translational R&D activities in the field of cell sheet tissue
engineering and its application to regenerative medicine. Thegoal and main
objective of CSTERM is to 1) gather experts and IPs and design pass way,
2) orchestrate both industrial and international partners globally by project,
and eventually 3) create an eco system to rescue patients from unmet medical
needs, where recent advances in regenerative medicine and tissue engineering
could be sustainably utilized for the benefit of those who are suffering
from various neglected diseases and disabilities, not onlyin Japan but
also globally.
Significant breakthroughs in applications of regenerative medicine have been seen both in scientific findings and in practices in recent years as a result of close collaboration between biomedical researchers, and clinical doctors. TWMU-TWIns (Tokyo Women’s Medical University-Waseda University Joint Institution for Advanced Biomedical Sciences ) has been instrumental in creating such an intensive collaboration for translational efforts, between academia and various industrial players, which helped materialize autologous clinical application of tissue engineering regenerative medicine technologies for the diseases of eye, heart, esophagus, periodontal and knee cartilage in the form of human clinical study or clinicaltrial. TWIns is the symbol of intensive fusion research and allied development of innovative advanced therapies.
However, to fully capitalize on those academic achievements and promote
not only autologous but also allogenic regenerative medicine for wide diffusion
backed by industrial partners and clinicians, we believe it is vital to
have an independent support organization to establish and manage a robust
framework to accelerate smooth flow of information & technologies among
various parties in collaboration with TWIns. An independent organization
outside of TWIns will encourage individuals and institutions with different
backgrounds or interests to join the activities in a flexible manner, thereby
attracting broad range of talents and other resources.
CSTERM is, not only supporting other research entities, but also initiating its own development of thermo-responsive smart cellculture surface (SSCW) applicable for various type of cells and smooth subculture process. To develop global translational research network of cell sheet regenerative medicine, CSTERM also accelerates networking of global academic collaborators, such as CSTEC@Utah at University of Utah.
We fully appreciate your understanding of existential value of CSTERM for researchers, clinicians and industry partners and encourage all to participate in cell sheet engineering R&D network to rescue patients worldwide.
Teruo Okano PhD.
Representative Director,
Cell Sheet Tissue Engineering Regenerative Medicine initiativeCSTERM
Emeritus Professor, Tokyo Women’s Medical University
Distinguished Adjunct Professor, University of Utah
Outline of CSTERM
Organization Name :Organization of Cell Sheet Tissue Engineering
Regenerative Medicine Initiatives “ CSTERM ”
(Generally Incorporated Association)
Address :
Ark Mori Building 36F, 1-12-32 Akasaka, Minato-ku, Tokyo,
107-6036
Sub-office (R&D) :
N205 TWIns 3F, Tokyo Women’s Medical University,
8-1 Kawada-cho, Shinjuku-Ku,Tokyo, 162-8666
Representative Director:
Teruo Okano (Emeritus Professor, Tokyo Women’s Medical
University)
Directors :
Mime Egami (Executive for Operation)
Kentoro Uryu (Legal/IP)
Hiroshi Egami (Business Development)
Auditor :
Kosuke Taguchi
Established : March 6th , 2017
Main Bank :Kasumigaseki Branch, Mitsui Sumitomo Bank